Baxter 2021 Corporate Responsibility Report 12 Corporate Responsibility Commitment 2030 Corporate Responsibility Goals Empower Our Patients Protect Our Planet Appendix Champion Our People and Communities Introduction Cross-Cutting Commitments United Nations Sustainable Development Goals We are proud to affirm our support for the United Nations Sustainable Development Goals (UN SDGs) and 2030 Agenda—a global blueprint for achieving a more sustainable future. While our business and corporate responsibility initiatives align with many of the UN SDGs, we focus especially on the goals highlighted below. As a global healthcare company, advancing health and well-being is central to our business. • To address the COVID-19 pandemic, we continue to protect our employees, increase the supply of critically necessary products and therapies, share our industry expertise and provide philanthropic support to communities in need. See COVID-19: Saving and Sustaining Lives During a Global Pandemic. • Through Baxter’s product donations, we work to address unmet healthcare needs and improve health outcomes in underserved communities. See Product Donations. • Through our Signature Partnerships, the Baxter International Foundation supports programs that increase access to healthcare. See Invest in Underserved Communities Globally . • Through a broad range of programs and activities, we are laying the foundation to increase access to peritoneal dialysis (PD) in developing countries. See Reach More Underserved Kidney Patients. • Through our ACT Initiative, Baxter launched a kidney care program to increase awareness and education in Black communities about kidney health and managing chronic kidney disease. Learn more. We take a broad approach to addressing water-related issues in Baxter’s operations and the communities where we operate. • We work to better understand the impacts of water use across our business and implement conservation and efficiency projects at our manufacturing facilities. See Implement Strategic Water Management Plans. • Using the World Resources Institute Aqueduct Water Risk Atlas version 3.0, we map and analyze current and future risks associated with water stress at our most significant water-use locations . See Water Management. • We take a proactive approach to wastewater operations and how we identify, evaluate and manage wastewater issues. See Wastewater . • In 2021, we continued our work to provide communities in Guatemala and India with access to clean water and launched a program in Colombia. See Supporting Access to Clean Water . Materials use is a key driver of Baxter’s environmental footprint and getting the most value possible from materials is central to our approach. • Through sustainable design, we minimize our environmental impacts and capture as much value as possible from the natural resources used to manufacture, transport, use and recover our products. See Sustainable Design. • Baxter’s corporate responsibility approach prioritizes compliance with product chemical and medical device regulations. See Materials of Concern. • We work to reduce materials use in products without affecting efficacy, and to avoid or minimize materials of concern. See Materials Use in Products and Packaging . • Baxter reduces the amount of materials used in packaging and substitutes with environmentally preferable alternatives when possible. See Packaging . • We work to reduce nonhazardous and regulated waste and to increase recycling at our manufacturing and office facilities. See Implement Strategic Materials and Waste Management Plans. • Baxter aims to conserve natural resources and reduce waste during product distribution. See Product Distribution. • We work with customers, industry peers and recycling and disposal vendors to facilitate the recycling and responsible treatment of medical products. See Product End-of-Life. ENSURE HEALTHY LIVES AND PROMOTE WELL-BEING FOR ALL AT ALL AGES ENSURE AVAILABILITY AND SUSTAINABLE MANAGEMENT OF WATER AND SANITATION FOR ALL ENSURE SUSTAINABLE CONSUMPTION AND PRODUCTION PATTERNS